Treatment of post-transfusion hyperhaemolysis syndrome in Sickle Cell Disease with the anti-IL6R humanised monoclonal antibody Tocilizumab

Br J Haematol. 2019 Sep;186(6):e212-e214. doi: 10.1111/bjh.16103. Epub 2019 Aug 1.
No abstract available

Keywords: haemolysis; sickle cell disease; transfusion medicine.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anemia, Sickle Cell / blood
  • Anemia, Sickle Cell / therapy*
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Erythrocyte Transfusion*
  • Hemolysis / drug effects*
  • Humans
  • Male
  • Syndrome
  • Transfusion Reaction / blood
  • Transfusion Reaction / drug therapy*

Substances

  • Antibodies, Monoclonal, Humanized
  • tocilizumab